Pharmaceuticals shortages including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products…
Ended Awarded Last action
- Contract number
- HT001418F0285
- Awardee
-
TDS Med, Inc. UEI L8RFE2B8JCK4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $249,999.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Woman-Owned Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $250,000 |
About this award
This contract was awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a woman-owned small business, on June 26, 2018. The $249,999.56 firm-fixed-price Blanket Purchase Agreement (BPA) Call has a period of performance through September 30, 2018. The contract is to provide various pharmaceutical products and supplies, including blood products, oncological pharmaceuticals, injectables, orals, and medicinal inhalations to address shortages. TDS Med, Inc. has previously provided similar products and services to federal agencies, including supporting COVID-19 response efforts. This award is part of a larger $2 million BPA held by TDS Med, Inc. with the DHA, which runs through September 2024 and allows for the issuance of task orders to fulfill pharmaceutical shortage requirements.
Description
Pharmaceuticals shortages including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations
Quick answers
Who was awarded contract HT001418F0285?
HT001418F0285 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on June 26, 2018.
How much is contract HT001418F0285 worth?
The government has obligated $250,000 on HT001418F0285.
Is contract HT001418F0285 an order under another contract?
Yes. HT001418F0285 is a BPA call under HT001414A0004, a blanket purchase agreement.
Was contract HT001418F0285 competed?
The extent of competition for HT001418F0285 was competed under sap. The government received 1 offer. It was set aside: Woman-Owned Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award